WallStSmart

National Health Investors Inc (NHI)vsVentas Inc (VTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ventas Inc generates 1410% more annual revenue ($6.11B vs $404.71M). NHI leads profitability with a 36.6% profit margin vs 4.3%. VTR appears more attractively valued with a PEG of 1.74. VTR earns a higher WallStSmart Score of 51/100 (C-).

NHI

Hold

48

out of 100

Grade: D+

Growth: 4.0Profit: 8.0Value: 6.0Quality: 3.5
Piotroski: 3/9Altman Z: 0.98

VTR

Buy

51

out of 100

Grade: C-

Growth: 7.3Profit: 4.5Value: 3.3Quality: 4.0
Piotroski: 4/9Altman Z: 0.43
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NHIUndervalued (+31.7%)

Margin of Safety

+31.7%

Fair Value

$129.13

Current Price

$70.43

$58.70 discount

UndervaluedFair: $129.13Overvalued
VTROvervalued (-9.8%)

Margin of Safety

-9.8%

Fair Value

$77.07

Current Price

$79.09

$2.02 premium

UndervaluedFair: $77.07Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NHI3 strengths · Avg: 9.3/10
Profit MarginProfitability
36.6%10/10

Keeps 37 of every $100 in revenue as profit

Operating MarginProfitability
61.3%10/10

Strong operational efficiency at 61.3%

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

VTR2 strengths · Avg: 8.0/10
Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
21.9%8/10

Revenue surging 21.9% year-over-year

Areas to Watch

NHI4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.762/10

Expensive relative to growth rate

Revenue GrowthGrowth
-2.6%2/10

Revenue declined 2.6%

EPS GrowthGrowth
-43.0%2/10

Earnings declined 43.0%

VTR4 concerns · Avg: 3.0/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Return on EquityProfitability
2.0%3/10

ROE of 2.0% — below average capital efficiency

Profit MarginProfitability
4.3%3/10

4.3% margin — thin

P/E RatioValuation
153.8x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : NHI

The strongest argument for NHI centers on Profit Margin, Operating Margin, Price/Book. Profitability is solid with margins at 36.6% and operating margin at 61.3%.

Bull Case : VTR

The strongest argument for VTR centers on Price/Book, Revenue Growth. Revenue growth of 21.9% demonstrates continued momentum.

Bear Case : NHI

The primary concerns for NHI are Piotroski F-Score, PEG Ratio, Revenue Growth.

Bear Case : VTR

The primary concerns for VTR are PEG Ratio, Return on Equity, Profit Margin. A P/E of 153.8x leaves little room for execution misses. Thin 4.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

NHI profiles as a declining stock while VTR is a growth play — different risk/reward profiles.

VTR carries more volatility with a beta of 0.73 — expect wider price swings.

VTR is growing revenue faster at 21.9% — sustainability is the question.

NHI generates stronger free cash flow (51M), providing more financial flexibility.

Bottom Line

VTR scores higher overall (51/100 vs 48/100) and 21.9% revenue growth. NHI offers better value entry with a 31.7% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

National Health Investors Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in the sale and leaseback, joint ventures, mortgages, and interim financing of discretionary and medical-based home and investment investments. in needs.

Visit Website →

Ventas Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.

Want to dig deeper into these stocks?